These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11910658)

  • 21. Bioavailability of estradiol from two transdermal patches.
    Setnikar I; Rovati LC; Vens-Cappell B; Hilgenstock C
    Arzneimittelforschung; 1996 Mar; 46(3):307-10. PubMed ID: 8901155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New trends in transdermal technologies: development of the skin patch, Menorest.
    Marty JP
    Int J Gynaecol Obstet; 1996 Mar; 52 Suppl 1():S17-20. PubMed ID: 8666122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous estradiol and levonorgestrel transdermal delivery from a 7-day patch: in vitro and in vivo drug deliveries of three formulations.
    Harrison LI; Zurth C; Gunther C; Karara AH; Melikian A; Lipp R
    Drug Dev Ind Pharm; 2007 Apr; 33(4):373-80. PubMed ID: 17523002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of pharmacokinetic profiles of a 17 beta-estradiol gel 0.6 mg/g (Gelestra) with a transdermal delivery system (Estraderm TTS 50) in postmenopausal women at steady state.
    Paoletti AM; Pilia I; Nannipieri F; Bigini C; Melis GB
    Maturitas; 2001 Dec; 40(3):203-9. PubMed ID: 11731181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An evaluation of bioequivalence of two 7-day 17beta-estradiol transdermal delivery systems by anatomical site.
    Harrison LL; Harari D
    J Clin Pharmacol; 2002 Oct; 42(10):1134-41. PubMed ID: 12362928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of estradiol and of estrone during application of three strengths of an estradiol transdermal patch with active matrix.
    Setnikar I; Rovati LC; Thebault JJ; Guillaume M; Mignot A; Renoux A; Gualano V
    Arzneimittelforschung; 1997 Jul; 47(7):859-65. PubMed ID: 9272245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol.
    Setnikar I; Rovati LC; Vens-Cappell B; Hilgenstock C
    Arzneimittelforschung; 1996 Aug; 46(8):766-73. PubMed ID: 9125276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estradiol and estrone plasma levels during application of three strengths of a 7-day estradiol transdermal patch.
    Setnikar I; Rovati LC; Santoro A; Guillaume M; Mignot A; Renoux A; Gualano V
    Arzneimittelforschung; 1999 Aug; 49(8):708-15. PubMed ID: 10483519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absorption and bioavailability of oestradiol from a gel, a patch and a tablet.
    Järvinen A; Nykänen S; Paasiniemi L
    Maturitas; 1999 Jun; 32(2):103-13. PubMed ID: 10465378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the pharmacokinetics of 17 beta-estradiol after a single 4-day application of Oesclim 50, Oesclim 100, and Vivelle 0.05 (Menorest 50) transdermal delivery systems.
    Guichard JP; Sauron R; Jones AB
    J Clin Pharmacol; 1999 Aug; 39(8):811-6. PubMed ID: 10434233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 17beta-estradiol matrixpatch removal and reapplication in postmenopausal women: theoretical predictions with an oscillating diffusion coefficient model.
    Rohr UD; Saeger-Lorenz K
    J Pharm Sci; 2002 Mar; 91(3):822-44. PubMed ID: 11920768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioavailability and pharmacodynamics of two 10-mg estradiol valerate depot formulations following IM single dose administration in healthy postmenopausal volunteers.
    Schug BS; Donath F; Blume HH
    Int J Clin Pharmacol Ther; 2012 Feb; 50(2):100-17. PubMed ID: 22257576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of continuous once-a-week combination 17β-Estradiol/Low- or high-dose levonorgestrel transdermal delivery systems in postmenopausal women.
    Karara AH; Harrison LI; Melikian AP; Poola N; Morrison D; Bourg D; Bourg L; Zurth C
    J Clin Pharmacol; 2014 May; 54(5):520-7. PubMed ID: 24474034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose proportionality study of four doses of an estradiol transdermal system, Estradot.
    Hossain M; Quebe-Fehling E; Sergejew T; Schmidt G; Skerjanec A; Ibarra de Palacios P; Krinsky L
    Maturitas; 2003 Nov; 46(3):173-85. PubMed ID: 14585520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of Fem7, a once-weekly, transdermal oestrogen replacement system in healthy, postmenopausal women.
    Geyer D; Gerrits MG; Renoux A; Uhl W
    Gynecol Obstet Invest; 1999; 48(1):1-6. PubMed ID: 10394083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of weekly transdermal estradiol controlled delivery system in postmenopausal Chinese.
    Chen GS; Zhang MY; Wang Q; Ye JC
    Zhongguo Yao Li Xue Bao; 1996 Sep; 17(5):407-10. PubMed ID: 9863160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Kinetics of a new patch for transdermal administration of 17 beta-estradiol].
    Rohr UD; Nauert C; Ehrly AM
    Zentralbl Gynakol; 1995; 117(10):531-9. PubMed ID: 7491836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studies.
    Rovati LC; Schmid K; Giacovelli G; Bonn M; Setnikar I; Wolff F; Genazzani AR
    Arzneimittelforschung; 1999 Nov; 49(11):933-43. PubMed ID: 10604047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steady-state pharmacokinetics following application of a novel transdermal estradiol spray in healthy postmenopausal women.
    Morton TL; Gattermeir DJ; Petersen CA; Day WW; Schumacher RJ
    J Clin Pharmacol; 2009 Sep; 49(9):1037-46. PubMed ID: 19628730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of a seven-day, transdermal estradiol drug-delivery system: comparison with conjugated estrogens and placebo. The Transdermal Estradiol Patch Study Group.
    Gordon SF; Thompson KA; Ruoff GE; Imig JR; Lane PJ; Schwenker CE
    Int J Fertil Menopausal Stud; 1995; 40(3):126-34. PubMed ID: 7663539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.